期刊文献+

35~40岁健康人群尿脱氧吡啶酚参考值研究

Urine Deoxypyridinoline Reference Level of the 35~40 Age Group
下载PDF
导出
摘要 目的获得佛山市35~40岁健康人群尿脱氧吡啶酚的参考值,为临床监测骨质疏松的发生及骨量丢失提供诊断依据。方法在本地区范围内,随机抽样收集213例正常男性和209例正常女性尿液标本,采用化学发光法检测尿脱氧吡啶酚,紫外酶法检测尿Cr,以nmolDPD/mmolCr比值为单位,对测量结果进行统计学处理。结果35~40岁健康人群尿脱氧吡啶酚参考值男性为1.47~6.52nmolDPD/mmolCr,女性为2.44~8.80nmolDPD/mmolCr,两者有显著性的差别(P<0.01)。结论35~40岁健康人群尿脱氧吡啶酚参考值有性别差异,应用时应区别对待。 Objective To obtain a reference level dinoline for 35-40 age group of urine deoxypyridinoline of the 35-40 age group. Methods Urine samples of 213 males and 209 females were analyzed. Urine deoxypyridinoline level was measured by chemiluminescence and urine Cr was measured by ultraviolet enzyme assay. Results The reference level of urine deoxypyridinoline for 35-40 age old local resident populations was 1.47-6.52 nmol DPD/ mmolCr for males and 2.44~8.80 nmol DPD/mmolCr for females. There was significant difference between the reference level for different sex (P〈 0.01 ).Coneluslon The reference level of urine deoxypyridinoline for 35-40 age old normal population is different between male and female, therefore the data should be interputed differently for different sex.
出处 《热带医学杂志》 CAS 2005年第6期824-826,共3页 Journal of Tropical Medicine
基金 广东省医学科研基金项目(No.A2002710)。
关键词 正常人群 脱氧吡啶酚 正常值 骨质疏松 normal population deoxypyridinoline normal measure osteopomsis
  • 相关文献

参考文献9

二级参考文献40

  • 1[1]ROBINS SP.Collagen crosslinks in metabolic bone disease[J].Acta Orthop Scand( Suppl266) ,1995,66:171-175.
  • 2[2]ROBINS SP,DUNCAN A,WILSON N,et al.Standardization of pyridinium crosslinks,pyridinoline and deoxypyridinoline,for use as biochemical markers of collagen degradation[J].Clin Chem,1996,42:1621-1626.
  • 3[3]ROBINS SP,BLACK D,PARTERSON CR,et al.Evaluation of urinary hydroxypyridinium crosslink measuremeants as resorption markers in metabolic bone diseases[J].Eur J Clin Invest,1991,21:310-315.
  • 4[4]DAVID R EYRE, THOMAS J KOOB,KIRK P VAN NESS. Quantitation of hydroxypyridinium crosslinks in collagen by high performance liquid chromatography[J].CAL Biochemistry ,1984,137: 380-388.
  • 5[5]SEBEL MJ,ROBINS SP,BILEZIKIAN JP.Urinary pyridinium crosslinks of collagen: specific markers of bone resorption in metabolic bone disease[J].Treads Endocrinol Metab,1992,3:263-270.
  • 6[6]BIENKOWSKI RS.Intracellular degradation of newly synthesixed collagen[J].Collagen Rel Res,1984,4:399-412.
  • 7[7]BLACK D,DUNCAN A,ROBINS SP.Quantitative analytical of the pyridinium crosslinks of collagen in urine using ion paired reversed ph ase high performance liquid chromatography[J].Anal Biochem,1988, 169:197-203.
  • 8[8]PRATT DA,DANILOFF Y,DUNCAN A,et al.Automated analysis of the pyridinium crosslinks of collagen in tissue and urine using solid phase extraction and reversed phase high performance liquid chromatography [J].Anal Biochem, 1992,207:168-175.
  • 9[9]GOMEZ B JR,ARDAKANI S,BRIAN J,et al.Monolonal antibody assay for free urinary pyridinium cross links[J].Clin Clem,1996,42(8):1158-1175.
  • 10[10]HANSON DA,WEIS ME,BOLLEN A,et al.A specific immunoassay for monitoring human bone resorption:quantitation of type I collagen crosslinked N telopeptides in urine[J].J Bone Miner Res,1992,7:1251-1258.

共引文献364

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部